Substance active (DCI)
- paclitaxel (dans une formulation de nanoparticules liées à l’albumine)
Informations techniques
Présentation
PAZENIR 5 mg/mL, poudre pour dispersion pour perfusion
1 flacon en verre de 100 mg (CIP : 34009 301 845 9 2)
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
RKbGjasqYPXRcWmn